Note: Molecular Toxicology Inc. D/B/A Moltox's revenues are gauged from an analysis of company filings.
Molecular Toxicology Inc. D/B/A Moltox's Income Statement (based on Industry Averages)
Molecular Toxicology Inc. D/B/A Moltox P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Molecular Toxicology Inc. D/B/A Moltox is developing and marketing.
Molecular Toxicology Inc. D/B/A Moltox doesn't have any recent trademark applications, indicating Molecular Toxicology Inc. D/B/A Moltox is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
MOLTOX FT Amino acids for laboratory or research use; Assays for research purposes; Cell growth media for growing cells for use in scientific research; Chemical preparations for scientific purposes; Enzymes for scientific and research purposes; Reagents for research purposes
12/08/2011
AMES FT Kits for laboratory use for identification of toxic substances primarily composed of bacterial inocula, cell growth media for reproducing bacteria for use in scientific research, exposure media in the nature of amino acids for laboratory or research use, and/or reversion indicator media in the nature of PH value measurement indicators, reagents for research purposes, and chemical preparations for scientific purposes in the nature of chemical control agents
05/16/2011
See all trademarks and details in the Full Report.
Market Share of Molecular Toxicology Inc. D/B/A Moltox's Largest Competitors
A competitive analysis shows these companies are in the same general field as Molecular Toxicology Inc. D/B/A Moltox, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Molecular Toxicology Inc. D/B/A Moltox.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
Future Competition: Molecular Toxicology Inc. D/B/A Moltox's Fastest Growing Competitors
These companies are in the same general field as Molecular Toxicology Inc. D/B/A Moltox and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.
My Watch List
